 Bennett Davenport
Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 8 | 2021 | 702 | 2.470 |
Why?
| | Chikungunya virus | 10 | 2024 | 63 | 2.210 |
Why?
| | Chikungunya Fever | 9 | 2024 | 63 | 2.070 |
Why?
| | Immunologic Memory | 5 | 2020 | 313 | 1.960 |
Why?
| | Lymphocytic choriomeningitis virus | 4 | 2019 | 20 | 1.530 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 170 | 0.960 |
Why?
| | Chemokines | 4 | 2020 | 230 | 0.950 |
Why?
| | Lymph Nodes | 5 | 2024 | 455 | 0.930 |
Why?
| | Lymphocytic Choriomeningitis | 2 | 2018 | 12 | 0.790 |
Why?
| | Arenaviridae Infections | 2 | 2019 | 7 | 0.760 |
Why?
| | CD4-Positive T-Lymphocytes | 4 | 2020 | 984 | 0.760 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 94 | 0.740 |
Why?
| | Alphavirus Infections | 4 | 2021 | 42 | 0.710 |
Why?
| | Joints | 1 | 2020 | 85 | 0.710 |
Why?
| | Aging | 2 | 2019 | 1670 | 0.680 |
Why?
| | Leishmania major | 1 | 2018 | 6 | 0.680 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 7 | 0.680 |
Why?
| | Mental Recall | 1 | 2019 | 180 | 0.650 |
Why?
| | Virulence Factors | 1 | 2018 | 140 | 0.600 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 339 | 0.580 |
Why?
| | Cytokines | 3 | 2020 | 1900 | 0.550 |
Why?
| | Mice | 20 | 2023 | 15520 | 0.490 |
Why?
| | Macrophages | 2 | 2022 | 1324 | 0.440 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 4908 | 0.430 |
Why?
| | Animals | 26 | 2024 | 33381 | 0.420 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 26 | 0.380 |
Why?
| | Viral Envelope Proteins | 2 | 2022 | 80 | 0.370 |
Why?
| | Adaptive Immunity | 3 | 2020 | 161 | 0.360 |
Why?
| | Receptors, Immunologic | 2 | 2021 | 209 | 0.350 |
Why?
| | Mice, Knockout | 6 | 2022 | 2680 | 0.340 |
Why?
| | Mice, Inbred BALB C | 3 | 2020 | 1206 | 0.330 |
Why?
| | Peromyscus | 2 | 2004 | 28 | 0.310 |
Why?
| | Insulin-Secreting Cells | 2 | 2022 | 330 | 0.280 |
Why?
| | Antiviral Agents | 2 | 2021 | 654 | 0.250 |
Why?
| | Mice, Transgenic | 6 | 2021 | 2025 | 0.240 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3730 | 0.240 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2014 | 310 | 0.240 |
Why?
| | Virulence | 3 | 2021 | 240 | 0.240 |
Why?
| | Immunization | 3 | 2024 | 412 | 0.240 |
Why?
| | Ross River virus | 2 | 2021 | 23 | 0.230 |
Why?
| | Kupffer Cells | 2 | 2021 | 47 | 0.230 |
Why?
| | Lectins, C-Type | 2 | 2020 | 63 | 0.220 |
Why?
| | Interferon Type I | 2 | 2021 | 129 | 0.220 |
Why?
| | Lymphoid Tissue | 2 | 2019 | 65 | 0.220 |
Why?
| | Salmonella | 1 | 2022 | 54 | 0.210 |
Why?
| | Virus Replication | 2 | 2022 | 405 | 0.200 |
Why?
| | Viral Vaccines | 1 | 2022 | 90 | 0.200 |
Why?
| | Viremia | 1 | 2021 | 132 | 0.190 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2021 | 394 | 0.190 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 8 | 0.190 |
Why?
| | Transcriptional Activation | 1 | 2022 | 348 | 0.190 |
Why?
| | Antibodies, Viral | 2 | 2022 | 542 | 0.180 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2022 | 279 | 0.180 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2445 | 0.180 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 18 | 0.180 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.180 |
Why?
| | Adoptive Transfer | 1 | 2020 | 204 | 0.180 |
Why?
| | Arthritis | 1 | 2020 | 112 | 0.170 |
Why?
| | Leishmania donovani | 1 | 2018 | 3 | 0.170 |
Why?
| | Parasite Load | 1 | 2018 | 8 | 0.170 |
Why?
| | Gene Deletion | 2 | 2018 | 361 | 0.160 |
Why?
| | Antigens, Viral | 1 | 2018 | 181 | 0.160 |
Why?
| | Nuclear Proteins | 2 | 2022 | 597 | 0.160 |
Why?
| | Dendritic Cells | 1 | 2021 | 442 | 0.150 |
Why?
| | Acute Disease | 1 | 2020 | 940 | 0.150 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 83 | 0.150 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2019 | 770 | 0.150 |
Why?
| | Glucose | 2 | 2022 | 953 | 0.150 |
Why?
| | Oxidative Stress | 2 | 2022 | 1178 | 0.150 |
Why?
| | Cells, Cultured | 4 | 2018 | 4077 | 0.150 |
Why?
| | TRPM Cation Channels | 2 | 2008 | 68 | 0.140 |
Why?
| | Bacterial Proteins | 1 | 2022 | 759 | 0.140 |
Why?
| | T-Lymphocyte Subsets | 2 | 2011 | 396 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2022 | 1055 | 0.140 |
Why?
| | Cell Survival | 1 | 2018 | 1047 | 0.130 |
Why?
| | Monocytes | 1 | 2017 | 513 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 632 | 0.130 |
Why?
| | Chronic Disease | 1 | 2020 | 1636 | 0.120 |
Why?
| | Cell Movement | 1 | 2018 | 896 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2017 | 310 | 0.120 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1284 | 0.110 |
Why?
| | Vaccination | 1 | 2021 | 1222 | 0.110 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2013 | 158 | 0.110 |
Why?
| | Male | 6 | 2020 | 57801 | 0.100 |
Why?
| | Neutrophils | 1 | 2017 | 1233 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2017 | 963 | 0.100 |
Why?
| | MicroRNAs | 1 | 2017 | 637 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1515 | 0.090 |
Why?
| | T-Lymphocytes | 3 | 2019 | 1774 | 0.090 |
Why?
| | Transcription Factors | 1 | 2018 | 1570 | 0.090 |
Why?
| | Immunodominant Epitopes | 1 | 2009 | 27 | 0.090 |
Why?
| | Parkinsonian Disorders | 1 | 2008 | 29 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2008 | 100 | 0.080 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2008 | 62 | 0.080 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1067 | 0.080 |
Why?
| | Viral Load | 2 | 2021 | 419 | 0.080 |
Why?
| | Endothelial Cells | 2 | 2024 | 732 | 0.070 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 143 | 0.070 |
Why?
| | RNA, Viral | 2 | 2021 | 572 | 0.070 |
Why?
| | Cloning, Molecular | 2 | 2004 | 546 | 0.070 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 381 | 0.070 |
Why?
| | Hemocyanins | 1 | 2004 | 57 | 0.060 |
Why?
| | Immune Sera | 1 | 2004 | 82 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 702 | 0.060 |
Why?
| | Lung | 1 | 2017 | 3664 | 0.060 |
Why?
| | Insulin | 2 | 2018 | 2162 | 0.060 |
Why?
| | Antigen-Presenting Cells | 1 | 2004 | 156 | 0.060 |
Why?
| | B-Lymphocytes | 2 | 2019 | 770 | 0.060 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2004 | 130 | 0.060 |
Why?
| | Female | 3 | 2020 | 61565 | 0.060 |
Why?
| | Humans | 14 | 2023 | 118974 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2004 | 273 | 0.060 |
Why?
| | Antigen Presentation | 1 | 2004 | 194 | 0.060 |
Why?
| | Interleukin-2 | 1 | 2004 | 416 | 0.060 |
Why?
| | Coculture Techniques | 1 | 2023 | 208 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 355 | 0.060 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2022 | 52 | 0.050 |
Why?
| | Interferon Regulatory Factors | 1 | 2022 | 31 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 2851 | 0.050 |
Why?
| | Phenylalanine | 1 | 2022 | 66 | 0.050 |
Why?
| | Alphavirus | 1 | 2021 | 17 | 0.050 |
Why?
| | Feedback | 1 | 2022 | 153 | 0.050 |
Why?
| | HeLa Cells | 1 | 2023 | 583 | 0.050 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 114 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2023 | 228 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 280 | 0.050 |
Why?
| | Protein Domains | 1 | 2022 | 212 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2018 | 2275 | 0.050 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 59 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 187 | 0.050 |
Why?
| | Viral Tropism | 1 | 2019 | 24 | 0.040 |
Why?
| | Cricetinae | 1 | 2020 | 262 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 576 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 322 | 0.040 |
Why?
| | Venules | 1 | 2018 | 13 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 13 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 300 | 0.040 |
Why?
| | Organelle Biogenesis | 1 | 2018 | 15 | 0.040 |
Why?
| | Conserved Sequence | 2 | 2009 | 219 | 0.040 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 4 | 0.040 |
Why?
| | Ovalbumin | 1 | 2018 | 165 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 67 | 0.040 |
Why?
| | Mitochondrial Dynamics | 1 | 2018 | 27 | 0.040 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 11 | 0.040 |
Why?
| | Stromal Cells | 1 | 2018 | 102 | 0.040 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2017 | 17 | 0.040 |
Why?
| | Antigens, Ly | 1 | 2017 | 45 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 30 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
| | Spleen | 1 | 2019 | 510 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 63 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 300 | 0.040 |
Why?
| | Lysine | 1 | 2019 | 248 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 87 | 0.040 |
Why?
| | Protein Subunits | 1 | 2018 | 211 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2018 | 174 | 0.040 |
Why?
| | Cadaver | 1 | 2018 | 327 | 0.040 |
Why?
| | Magnesium | 2 | 2008 | 150 | 0.040 |
Why?
| | Cell Degranulation | 1 | 2016 | 38 | 0.040 |
Why?
| | Granzymes | 1 | 2016 | 40 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 311 | 0.040 |
Why?
| | Epitopes | 1 | 2018 | 443 | 0.030 |
Why?
| | RNA Interference | 1 | 2018 | 460 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 204 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 281 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2018 | 586 | 0.030 |
Why?
| | Mutation | 2 | 2021 | 3457 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 151 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 653 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2021 | 745 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 4 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 325 | 0.030 |
Why?
| | Cell Membrane | 2 | 2008 | 710 | 0.030 |
Why?
| | Thymus Gland | 1 | 2014 | 300 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 3360 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2008 | 2071 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2011 | 25 | 0.030 |
Why?
| | CD28 Antigens | 1 | 2011 | 46 | 0.030 |
Why?
| | Viruses | 1 | 2013 | 96 | 0.030 |
Why?
| | Pneumonia | 1 | 2017 | 592 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2011 | 69 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2871 | 0.030 |
Why?
| | Transcriptome | 1 | 2016 | 756 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5392 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1085 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2009 | 41 | 0.020 |
Why?
| | Amino Acids, Diamino | 1 | 2008 | 1 | 0.020 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2008 | 8 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2009 | 49 | 0.020 |
Why?
| | Guam | 1 | 2008 | 7 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1753 | 0.020 |
Why?
| | Hybridomas | 1 | 2009 | 233 | 0.020 |
Why?
| | Proline | 1 | 2008 | 71 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2008 | 85 | 0.020 |
Why?
| | Leucine | 1 | 2008 | 117 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4709 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 574 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 305 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2566 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2008 | 219 | 0.020 |
Why?
| | Bacteria | 1 | 2013 | 757 | 0.020 |
Why?
| | Autoantigens | 1 | 2009 | 397 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 62 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 622 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2008 | 454 | 0.020 |
Why?
| | Models, Molecular | 1 | 2008 | 1435 | 0.010 |
Why?
| | Cell Division | 1 | 2005 | 776 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 268 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 1975 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 336 | 0.010 |
Why?
| | Calcium | 1 | 2008 | 1169 | 0.010 |
Why?
| | Interleukins | 1 | 2004 | 242 | 0.010 |
Why?
| | Homeostasis | 1 | 2005 | 594 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 982 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1633 | 0.010 |
Why?
| | Cell Line | 1 | 2005 | 2707 | 0.010 |
Why?
|
|
Davenport's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|